These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 34591178)
1. Influence of lactide vs glycolide composition of poly (lactic-co-glycolic acid) polymers on encapsulation of hydrophobic molecules: molecular dynamics and formulation studies. Dobhal A; Srivastav A; Dandekar P; Jain R J Mater Sci Mater Med; 2021 Sep; 32(10):126. PubMed ID: 34591178 [TBL] [Abstract][Full Text] [Related]
2. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles. Panyam J; Sahoo SK; Prabha S; Bargar T; Labhasetwar V Int J Pharm; 2003 Aug; 262(1-2):1-11. PubMed ID: 12927382 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel coumarin-triazole hybrids and first evaluation of the 4-phenyl substituted hybrid loaded PLGA nanoparticles delivery system to the anticancer activity. Arvas B; Ucar B; Acar T; Varli HS; Arvas MB; Aydogan F; Yolacan C Nanotechnology; 2024 May; 35(30):. PubMed ID: 38636487 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid). Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829 [TBL] [Abstract][Full Text] [Related]
6. Polyelectrolyte coated polymeric nanoparticles for controlled release of docetaxel. Agrawal R; Shanavas A; Yadav S; Aslam M; Bahadur D; Srivastava R J Biomed Nanotechnol; 2012 Feb; 8(1):19-28. PubMed ID: 22515091 [TBL] [Abstract][Full Text] [Related]
7. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. Panyam J; Williams D; Dash A; Leslie-Pelecky D; Labhasetwar V J Pharm Sci; 2004 Jul; 93(7):1804-14. PubMed ID: 15176068 [TBL] [Abstract][Full Text] [Related]
8. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. Nair K L; Jagadeeshan S; Nair SA; Kumar GS Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233 [TBL] [Abstract][Full Text] [Related]
9. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing. Witschi C; Doelker E J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930 [TBL] [Abstract][Full Text] [Related]
11. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives. Chung TW; Tsai YL; Hsieh JH; Tsai WJ J Microencapsul; 2006 Feb; 23(1):15-27. PubMed ID: 16830974 [TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and uptake of PEG-coated, muco-inert nanoparticles in HGC-27 cells, a mucin-producing, gastric-cancer cell line. Lin D; Li G; Qin L; Wen Z; Wang J; Sun X J Biomed Nanotechnol; 2013 Dec; 9(12):2017-23. PubMed ID: 24266257 [TBL] [Abstract][Full Text] [Related]
13. Nanoparticles made of fluorescence-labelled Poly(L-lactide-co-glycolide): preparation, stability, and biocompatibility. Weiss B; Schaefer UF; Zapp J; Lamprecht A; Stallmach A; Lehr CM J Nanosci Nanotechnol; 2006; 6(9-10):3048-56. PubMed ID: 17048517 [TBL] [Abstract][Full Text] [Related]
14. Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells. Intra J; Salem AK J Drug Target; 2011 Jul; 19(6):393-408. PubMed ID: 20681752 [TBL] [Abstract][Full Text] [Related]
15. Copolymer Composition and Nanoparticle Configuration Enhance in vitro Drug Release Behavior of Poorly Water-soluble Progesterone for Oral Formulations. Zhang Y; Zhang R; Illangakoon UE; Harker AH; Thrasivoulou C; Parhizkar M; Edirisinghe M; Luo CJ Int J Nanomedicine; 2020; 15():5389-5403. PubMed ID: 32801695 [TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4. Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482 [TBL] [Abstract][Full Text] [Related]
17. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip. Grayson AC; Voskerician G; Lynn A; Anderson JM; Cima MJ; Langer R J Biomater Sci Polym Ed; 2004; 15(10):1281-304. PubMed ID: 15559850 [TBL] [Abstract][Full Text] [Related]
18. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins. Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502 [TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA. Basarkar A; Devineni D; Palaniappan R; Singh J Int J Pharm; 2007 Oct; 343(1-2):247-54. PubMed ID: 17611054 [TBL] [Abstract][Full Text] [Related]
20. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery. Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]